Evaluation of airway and circulating inflammatory biomarkers for cystic fibrosis drug development is a research paper published in Journal of Cystic Fibrosis (2020). On theSindex it has a DataRank of 0.892. It has been cited 24 times, with 21 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0.409
From 16 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 21 citers.
National Center for Advancing Translational Sciences
Grant: UL1 TR002535
Cystic Fibrosis Foundation Therapeutics
Grant: AQUADEK12K1
National Institutes of Health
Grant: 3UL1TR002535-03S1
NIH Prior Approval Process Professional
Cystic Fibrosis Foundation
National Institutes of Health
FWCI
0.99
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals